Forte Biosciences (FBRX) FCF Margin (2017 - 2019)
Forte Biosciences' (FBRX) quarterly FCF Margin came in at 8244.44% in Q4 2019, up 12081111.0% year-on-year from N/an in Q4 2018, and down 25.98% on a QoQ basis from 6544.44% in Q3 2019.
Forte Biosciences (FBRX) FCF Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of FCF Margin data on file, last reported at 8244.44% in Q4 2019.
- On a quarterly basis, FCF Margin rose 12081111.0% year-over-year to 8244.44% in Q4 2019; TTM through Dec 2019 was 8147.22%, a 795512.0% decrease from a year earlier, with the FY2019 full-year figure at 8147.22%, down 795512.0% from the prior year.
- FCF Margin for Q4 2019 stood at 8244.44%, down from 6544.44% in the prior quarter.
- Over the last five years, FCF Margin for FBRX reached as high as 178955.56% in Q2 2019 and fell as low as 196755.56% in Q1 2019.
- Historically, FCF Margin has averaged 61282.77% across 3 years, with a median of 74350.0% in 2017.
- On a YoY basis, FCF Margin climbed as much as 30778889 bps in 2019 and fell as far as 5505556 bps in 2019.
- Year by year, FCF Margin stood at 96660.0% in 2017, then slumped by 34 bps to 129055.56% in 2018, then soared by 94 bps to 8244.44% in 2019.
- Per Business Quant data, the three most recent FCF Margin figures were 8244.44% in Q4 2019, 6544.44% in Q3 2019, and 178955.56% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -8,244.44% |
| Sep 30, 2019 | -6,544.44% |
| Jun 30, 2019 | 178,955.56% |
| Mar 31, 2019 | -196,755.56% |
| Dec 31, 2018 | -129,055.56% |
| Sep 30, 2018 | 7.31% |
| Jun 30, 2018 | -128,833.33% |
| Mar 31, 2018 | -141,700.00% |
| Dec 31, 2017 | -96,660.00% |
| Sep 30, 2017 | -70,930.00% |
| Jun 30, 2017 | -74,350.00% |